Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112700-112700
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
Jiawei Zuo, Tao Meng, Yuanyuan Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 641-641
Open Access | Times Cited: 26
Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study
Marí­a Elena Soto, Israel Pérez-Torres, Linaloe Manzano-Pech, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4543-4543
Open Access | Times Cited: 4
The Redox Homeostasis Alteration Is Restored by Melatonin Treatment in COVID-19 Patients
Marí­a Elena Soto, Israel Pérez-Torres, Linaloe Manzano-Pech, et al.
(2024)
Open Access | Times Cited: 3
The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance
Md. Rezaul Islam, Md. Mominur Rahman, Md. Tanjimul Ahasan, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 46, pp. 69341-69366
Open Access | Times Cited: 20
N-Acetyl Cysteine Restores the Diminished Activity of the Antioxidant Enzymatic System Caused by SARS-CoV-2 Infection: Preliminary Findings
Marí­a Elena Soto, Linaloe Manzano-Pech, Adrián Palacios Chavarría, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 591-591
Open Access | Times Cited: 9
Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery
Suaidah Ramli, Yuan Seng Wu, Kalaivani Batumalaie, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 8
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation
Shangxin Yang, Ashrit Multani, Jacob M. Garrigues, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2096-2096
Open Access | Times Cited: 8
Analysis of the SARS-CoV-2 nsp12 P323L/A529V mutations: coeffect in the transiently peaking lineage C.36.3 on protein structure and response to treatment in Egyptian records
Dina Nadeem Abd‐Elshafy, Rola Nadeem, Mohamed H. Nasraa, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 1-2, pp. 13-24
Open Access | Times Cited: 2
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
Igor Aurer, Ozren Jakšić, Sandra Bašić‐Kinda, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 331-331
Open Access | Times Cited: 2
Designing an Efficient Biocatalyst for the Phosphoribosylation of Antiviral Pyrazine-2-carboxamide Derivatives
Evgeniy A. Zayats, Ilya V. Fateev, Y.A. Abramchik, et al.
ACS Catalysis (2024) Vol. 14, Iss. 5, pp. 3687-3699
Closed Access | Times Cited: 2
Favipiravir attachment to a conical nanocarbon: DFT assessments of the drug delivery approach
Kun Harismah, Seyed Abbas Shahrtash, Azar Arabi, et al.
Computational and Theoretical Chemistry (2022) Vol. 1216, pp. 113866-113866
Closed Access | Times Cited: 12
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Michał Brzdęk, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2371-2371
Open Access | Times Cited: 6
Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism
Oleksandr Oliynyk, Marta Rorat, Serhij Oleksandrovych Solyarik, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1513-1513
Open Access | Times Cited: 6
COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
Agata Michalak, Tomasz Lach, Karolina Szczygieł, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2212-2212
Open Access | Times Cited: 1
Mortality, Intensive Care Unit Admission, and Intubation among Hospitalized Patients with COVID-19: A One-Year Retrospective Study in Jordan
Khaled Al Oweidat, Rasmieh Al‐Amer, Mohammad Saleh, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2651-2651
Open Access | Times Cited: 3
Divergences in Antiviral Therapy for Diabetic Patients with COVID-19
Andreea Fitero, Nicoleta Negruț, Carmen Delia Nistor-Cseppento, et al.
(2024)
Open Access
Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods
Mir Saleh Hoseininezhad-Namin, Elaheh Rahimpour, Abolghasem Jouyban
Drug Metabolism Reviews (2024) Vol. 56, Iss. 2, pp. 127-144
Closed Access
EFFECTS OF ANTIVIRAL THERAPEUTIC DRUGS FOR SARS-COV-2 ON TREATMENT OUTCOMES AND CLINICAL PARAMETERS
Abdul Bari, Atiqullah Sarwari, Mohammad Hassan, et al.
Eurasian Journal of Ecology (2024) Vol. 79, Iss. 2, pp. 136-146
Open Access
Analysis of risk factors for painful diabetic peripheral neuropathy and construction of a prediction model based on Lasso regression
Zikai Yu, Sue Zhao, Jing Cao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Sub-acute toxicity of the standardised extract of Boesenbergia rotunda in rats
Pinnakarn Techapichetvanich, Phisit Khemawoot, Passaraporn Srimangkornkaew, et al.
ScienceAsia (2024) Vol. 50, Iss. 3, pp. 1-1
Open Access
Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing
Abhishek Chaurasiya, Abhimannu Shome, Pooja A. Chawla
Exploration of Medicine (2023), pp. 33-44
Open Access | Times Cited: 1
Pharmacokinetic Interaction Between Favipiravir and Amlodipine in Hypertensive Local Rabbits (Oryctolagus cuniculus)
Ali I. Al-ameedi, Falah Muosa Kadhim Al-Rekabi
The Iraqi Journal of Veterinary Medicine (2023) Vol. 47, Iss. 1, pp. 38-43
Open Access | Times Cited: 1
Prophylactic and Therapeutic Potential Zinc Metallodrugs Drug Discovery: Identification of SARS-CoV-2 Replication and Spike/ACE2 Inhibitors
Mpho Phehello Ngoepe, Kgaugelo C. Tapala, Hadley S. Clayton
Current Computer - Aided Drug Design (2022) Vol. 18, Iss. 7, pp. 519-534
Closed Access | Times Cited: 2
Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic
Iqra Mir, Sania Aamir, Syed Rizwan Hussain Shah, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 2, pp. 84-100
Open Access | Times Cited: 1
DIGESTIVE MANIFESTATIONS IN PATIENTS WITH COVID-19
Cristina M. MACREA, Emilia C. POPA, I. Paul, et al.
Archives of the Balkan Medical Union (2023) Vol. 58, Iss. 3, pp. 264-272
Open Access
Page 1 - Next Page

Scroll to top